Sté Tunisienne des Maladies Respiratoires et d'Allergologie
Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis
RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis.
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
The post RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis. appeared first on Links Medicus.
-
Taille de police
Réduire la taille de la police
Augmenter la taille de police
About Author
Dernier de Zouhair Souissi
- M-A | Catheter-directed thrombolysis vs. systemic thrombolysis and anticoagulation in intermediate- or high-risk pulmonary embolism
- AHA Scientific Statement | Pulmonary hypertension in congenital heart disease
- RCT | Cytisinicline shows significant efficacy in smoking cessation over placebo
- M-A | Adjunctive corticosteroids improve survival, clinical outcomes in severe community-acquired pneumonia
- M-A | Drug therapies for treatment of idiopathic pulmonary fibrosis
Laissez un commentaire
Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.